Macrophages in resistance to candidiasis

Microbiology and Molecular Biology Reviews

Volumn 61, Issue 2, 1997, Pages 170-192

  Vázquez Torres, Andrés ^a,b   Balish, Edward ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ALBICANS; CANDIDIASIS; FUNGICIDAL ACTIVITY; HUMAN; INFECTION RESISTANCE; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PHAGOCYTOSIS; REVIEW; T LYMPHOCYTE;

CANDIDA ALBICANS; FUNGI;

EID: 0030790688     PISSN: 10922172     EISSN: None     Source Type: Journal    
DOI: 10.1128/.61.2.170-192.1997     Document Type: Review

References (278)

1. Abel, G., and J. K. Czop. 1992. Stimulation of human monocyte β-glucan receptors by glucan particles induces production of TNF-α and IL-1β. Int. J. Immunopharmacol. 14:1363-1373.
2. Al-Doory, Y. 1970. An immune factor in baboon anti-Candida serum. Sabouraudia 8:41-47.
3. Allendoerfer, R., D. M. Magge, J. G. Smith, L. Bonewald, and J. R. Graybill. 1993. Induction of tumor necrosis factor-α in murine Candida albicans infection. J. Infect. Dis. 167:1168-1172.
4. Anderson, J. M., and D. R. Soll. 1987. Unique phenotype of opaque cells in the white-opaque transition of Candida albicans. J. Bacteriol. 169:5579-5588.
5. Arai, T., Y. Mikami, and K. Yokoyama. 1977. Phagocytosis of C. albicans by rabbit alveolar macrophages and guinea pig neutrophils. Sabouraudia 15: 171-177.
6. Ashman, R. B. 1990. Murine candidiasis: cell-mediated immune responses correlate directly with susceptibility and resistance to infection. Immunol. Cell Biol. 68:15-20.
7. Ashman, R. B., and J. M. Papadimitriu. 1990. What's new in the mechanisms of host resistance to Candida albicans infection? Pathol. Res. Pract. 186:527-534.
8. Ashman, R. B., and J. M. Papadimitriu. 1995. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol. Rev. 59:646-672.
9. Baccarini, M., F. Bistoni, P. Puccetti, and E. Garaci. 1983. Natural cell-mediated cytotoxicity against C. albicans induced by cyclophosphamide: nature of the in vitro cytotoxic effector. Infect. Immun. 42:1-9.
10. Baccarini, M., A. F. Kiderlen, T. Decker, and M.-L. Lotmann-Matthes. 1986. Functional heterogeneity of murine macrophage precursor cells from spleen and bone marrow. Cell. Immunol. 101:339-350.
11. Balish, E., M. J. Balish, C. A. Salkowski, K. W. Lee, and K. F. Bartizal. 1984. Colonization of congenitally athymic gnotobiotic mice by Candida albicans. Appl. Environ. Microbiol. 47:647-652.
12. Balish, E., H. Filutowicz, and T. D. Oberley. 1990. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect. Immun. 58:107-113.
13. Bancroft, G. J., R. D. Schreiber, and E. R. Unanue. 1991. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the SCID mouse. Immunol. Rev. 124:5-24.
14. Beckerman, K. P., H. W. Rogers, J. A. Corbett, R. D. Schreiber, M. L. McDaniel, and E. R. Unanue. 1993. Release of nitric oxide during the T cell-independent pathway of macrophage activation. J. Immunol. 150:888-895.
15. Benjamin, N., F. O'Driscoll, H. Dougall, C. Duncan, L. Smith, M. Golden, and H. McKenzie. 1994. Stomach NO synthesis. Nature 368:502.
16. + lymphocytes. J. Immunol. 154:5273-5281.
17. Bistoni, F., A. Vecchiarelli, E. Cenci, P. Puccetti, P. Marcone, and A. Cassone. 1986. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect. Immun. 51:668-674.
18. Blasi, E., A. Bartoli, R. Barluzzi, R. Mazzolla, and F. Bistoni. 1994. Pattern of cytokine gene expression in brains of mice protected by picolinic acid against lethal intracerebral infection with Candida albicans. J. Neuroimmunol. 52:205-213.
19. Blasi, E., S. Farinelli, L. Varesio, and F. Bistoni. 1990. Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1. Infect. Immun. 58: 1073-1077.
20. Blasi, E., L. Pitzurra, M. Puliti, A. R. Chimienti, R. Mazzolla, R. Barluzzi, and F. Bistoni. 1995. Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds. Infect. Immun. 63:1806-1809.
21. Blasi, E., L. Pitzurra, M. Puliti, L. Lanfrancone, and F. Bistoni. 1992. Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans. Infect. Immun. 60:832-837.
22. Blasi, E., M. Puliti, L. Pitzurra, A. Bartoli, and F. Bistoni. 1994. Heterogeneous secretory response of phagocytes from different anatomical districts to the dimorphic fungus Candida albicans. Cell. Immunol. 153:219-247.
23. Bortolussi, R., G. Faulkner, S. H. Lee, and R. Ozere. 1981. Phagocytosis of Candida albicans in chronic mucocutaneous candidiasis. Pediatr. Res. 15: 1287-1242.
24. Brummer, E., L. H. Hanson, A. Restrepo, and D. A. Stevens. 1988. In vivo and in vitro activation of pulmonary macrophages by interferon-gamma for enhanced killing of Paracoccidiodes brasiliensis or Blastomyces dermatitides. J. Immunol. 140:2786-2789.
25. Brummer, E., C. J. Morrison, and D. A. Stevens. 1985. Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect. Immun. 49:724-7311.
26. Brummer, E., and D. A. Stevens. 1987. Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines. Clin. Exp. Immunol. 70:520-528.
27. Brummer, E., and D. A. Stevens. 1989. Candidacidal mechanisms of peritoneal macrophages activated with lymphokines of gamma-interferon. J. Med. Microbiol. 28:173-181.
28. Busolo, F., L. Conventi, M. Grigolon, P. Bassi, C. Milani, A. Meneghini, and F. Pagano. 1993. Effects of bacillus of Calmette-Guerin, Candida albicans and human recombinant interferon-gamma on RNA metabolism and on in vitro release of tumor necrosis factor-α by human monocytes/macrophages. Microbiologica 16:259-266.
29. Byrd, T. F., and M. A. Horwitz. 1993. Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J. Clin. Invest. 91:969-976.
30. Calderone, R. A., and P. C. Braun. 1991. Adherence and receptor relationships of Candida albicans. Microbiol. Rev. 55:1-20.
31. Calderone, R. A., and J. Sturtevant. 1994. Macrophage interactions with Candida albicans. Immunol. Ser. 60:505-515.
32. Cantorna, M., D. Mook, and E. Balish. 1990. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis. Infect. Immun. 58:3813-3815.
33. Cantorna, M. T., and E. Balish. 1990. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 58:1093-1100.
34. + lymphocytes in resistance to mucosal candidiasis. Infect. Immun. 59:2447-2455.
35. Casadevall, A. 1995. Antibody immunity and invasive fungal infections. Infect. Immun. 63:4211-4218.
36. Castro, M., J. A. Bjoraker, M. S. Rohrbach, and A. H. Limper. 1996. Candida albicans induces the release of inflammatory mediators from human peripheral blood monocytes. Inflammation 20:107-122.
37. Castro, M., N. V. Ralston, T. I. Morgenthaler, M. S. Rohrbach, and A. H. Limper. 1994. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through α-mannan and β-glucan cell wall components. Infect. Immun. 62:3138-3145.
38. Cenci, E., L. Romani, A. Mencacci, R. Spaccapelo, E. Schiaffella, P. Puccetti, and P. Bistoni. 1993. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of C. albicans. Eur. J. Immunol. 23: 1034-1038.
39. + lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infect. Immun. 57:3581-3587.
40. Chakir, J., L. Cote, C. Coulombe, and N. Deslauriers. 1994. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol. Immunol. 9:88-94.
41. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
42. Chaturvedi, S., P. Frame, and S. L. Newman. 1995. Macrophages from human immunodeficiency virus-positive persons are defective in host defense against Histoplasma capsulatum. J. Infect. Dis. 171:320-327.
43. Clift, R. A. 1984. Candidiasis in the transplant patient. Am. J. Med. 77(4D): 34-38.
44. Cline, M. J., and R. I. Lehrer. 1968. Phagocytosis by human monocytes. Blood 32:423-435.
45. Coker, L. A. III, C. M. Mercadal, B. T. Rouse, and R. N. Moore. 1992. Differential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis. J. Leukocyte Biol. 51:305-306.
46. Cole, G. T., K. Saha, K. R. Seshan, K. T. Lynn, M. Frence, and P. K. Y. Wong. 1992. Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis. Infect. Immun. 60:4168-4178.
47. Cole, G. T., A. A. Halawa, and E. J. Anaissie. 1996. The role of gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin. Infect. Dis. 22(Suppl. 2):S73-S88.
48. Costa-Casnellie, M. R., G. B. Segel, and M. A. Lichtman. 1985. Concanavalin A and phorbol ester cause opposite subcellular redistribution of protein kinase C. Biochem. Biophys. Res. Commun. 133:1139-1144.
49. Crowe, S. M., N. J. Vardaxis, S. J. Kent, A. L. Maerz, M. J. Hewish, M. S. McGrath, and J. Mills. 1994. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J. Leukocyte Biol. 56:318-327.
50. Cuff, C. F., C. M. Rogers, B. J. Lamb, and T. J. Rogers. 1986. Induction of suppressor cells in vitro by C. albicans. Cell. Immunol. 100:47-56.
51. Cuff, C. F., D. D. Taub, and T. J. Rogers. 1989. The induction of T suppressor cells with a soluble extract of C. albicans. Cell. Immunol. 122: 71-82.
52. Curnutte, J. T. 1993. Chronic granulomatous disease: the solving of a clinical riddle at the molecular level. Clin. Immunol. Immunopathol. 67: S2-S15.
53. Cutler, J. E. 1976. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J. Reticuloendothel. Soc. 19:121-124.
54. Cutler, J. E., and A. H. Poor. 1981. Effect of mouse phagocytes on Candida albicans in in vivo chambers. Infect. Immun. 31:1110-1116.
55. Czop, J. K., and K. F. Austen. 1985. Generation of leukotrienes by human monocytes upon stimulation of their β-glucan receptor during phagocytosis. Proc. Natl. Acad. Sci. USA 82:2751-2755.
56. Czop, J. K., and K. F. Austen. 1985. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte β-glucan receptor. J. Immunol. 135:3388-3393.
57. Dale, D. C., D. Guerry IV, J. R. Wewerka, J. M. Bull, and M. J. Chusid. 1979. Chronic neutropenia. Medicine 58:128-144.
58. Danley, D. L., and F. Polakoff. 1986. Rapid killing of monocytes in vitro by Candida albicans yeast cells. Infect. Immun. 51:307-313.
59. Daum, T., and M. S. Rohrbach. 1992. Zymosan induces selective release of arachidonic acid from rabbit alveolar macrophages via stimulation of a β-glucan receptor. FEBS Lett. 309:114-122.
60. Decker, T., M. Baccarini, and M.-L. Lohmann-Matthes. 1986. Liver-associated macrophage precursors as natural cytotoxic effectors against Candida albicans and Yac-1 cells. Eur. J. Immunol. 16:693-699.
61. Decker, T., M.-L. Lohmann-Matthes, and M. Baccarini. 1986. Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans. Infect. Immun. 54:477-486.
62. De Groote, M. A., T. Testerman, Y. Xu, G. Stauffer, and F. C. Fang. 1996. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 272:414-417.
63. Denis, M. 1991. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukocyte Biol. 49:380-387.
64. Denis, M. 1994. Human monocytes/macrophages: NO or no NO? J. Leukocyte Biol. 55:682-684.
65. Denlinger, L. C., P. L. Fisette, K. A. Garis, G. Kwon, A. Vazquez-Torres, A. D. Simon, B. Nguyen, R. A. Proctor, P. J. Bertics, and J. A. Corbett. 1996. Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J. Biol. Chem. 271:337-342.
66. Diamond, R. D., R. A. Clark, and C. C. Haudenschild. 1980. Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J. Clin. Invest. 66:908-917.
67. Diamond, R. D., and C. C. Haudenschild. 1981. Monocyte-mediated serum-independent damage to hyphal and pseudohyphal forms of C. albicans in vitro. J. Clin. Invest. 67:173-182.
68. Diamond, R. D., C. A. Lyman, and D. R. Wysong. 1991. Disparate effects of interferon-γ and tumor necrosis factor-α on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro. J. Clin. Invest. 87:711-720.
69. Djeu, J. Y., D. K. Blanchard, A. L. Richards, and H. Friedman. 1988. Tumor necrosis factor induction by C. albicans from human natural killer cells and monocytes. J. Immunol. 141:4047-4052.
70. Duncan, S., H. Dougall, P. Johnston, S. Green, R. Brogan, C. Leifert, L. Smith, M. Golden, and N. Benjamin. 1995. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat. Med. 1:546-551.
71. Elstad, M. R., C. J. Parker, F. S. Cowley, L. A. Wilcox, T. M. McIntyre, S. M. Presott, and G. A. Zimmerman. 1994. CD11b/CD18 integrin and a β-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes. J. Immunol. 152:220-230.
72. Enelow, R. I., G. W. Sullivan, H. T. Carper, and G. L. Mandell. 1992. Cytokine-induced human multinucleated giant cells have enhanced candidacidal activity and oxidative capacity compared with macrophages. J. Infect. Dis. 166:664-668.
73. Evron, R. 1980. In vitro phagocytosis of Candida albicans by peritoneal mouse macrophages. Infect. Immun. 28:963-971.
74. Ezekowitz, R. A. B. 1992. The mannose receptor and phagocytosis, p. 208-213. In R. van Furth (ed.), Mononuclear phagocytes. Kluwer Academic Publishers, Boston, Mass.
75. Felipe, I., E. E. Bochio, N. B. Martins, and C. Pacheco. 1991. Inhibition of macrophage phagocytosis of E. coli by mannose and mannan. Braz. J. Med. Biol. Res. 24:919-924.
76. Fidel, P. L., Jr., M. E. Lynch, D. H. Conaway, L. Tait, and J. D. Sobel. 1995. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect. Immun. 63:547-553.
77. Fidel, P. L., Jr., N. A. Wolf, and M. A. KuKuruga. 1996. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in periphery. Infect. Immun. 64:3793-3799.
78. Fleischmann, J., and R. I. Lehrer. 1985. Phagocytic mechanisms in host response, p. 123-149. In D. H. Howard (ed.), Fungi pathogenic for humans and animals, part B. Pathogenicity and detection II. Marcel Dekker, Inc., New York, N.Y.
79. Flesch, I. E. A., and S. H. E. Kaufmann. 1988. Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages. Infect. Immun. 56:1464-1469.
80. Fradin, C., T. Jouault, A. Mallet, J.-M. Mallet, D. Camus, P. Sinaÿ, and D. Poulain. 1996. β-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage. J. Leukocyte Biol. 60:81-87.
81. Fromtling, R. A., and H. J. Shadomy. 1986. An overview of macrophage-fungal interactions. Mycopathologia 93:77-93.
82. Fujita, T., S. Taira, N. Kodama, M. Matsushita, and T. Fujita. 1995. Mannose-binding protein recognizes glioma cells: in vitro analysis of complement activation on glioma cells via the lectin pathway. Jpn. J. Cancer Rev 86:187-191
83. Ganser, A., O. G. Ottmann, H. Erdmann, G. Schultz, and D. Hoelser. 1989. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia. Ann. Intern. Med. 111:887-892.
84. Garcha, U. K., E. Brummer, and D. A. Stevens. 1995. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing Candida species. J. Infect. Dis. 172:1620-1623.
85. Garner, R. E., A. M. Childress, L. G. Human, and J. E. Domer. 1990. Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells. Infect. Immun. 58:2613-2620.
86. Garner, R. E., U. Kuruganti, C. W. Czarniecki, H. H. Chiu, and J. E. Domer. 1989. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Infect. Immun. 57:1800-1808.
87. Garner, R. E., K. Rubanowice, R. T. Sawyer, and J. A. Hudson. 1944. Secretion of TNF-α by alveolar macrophages in response to Candida albicans mannan. J. Leukocyte Biol. 55:161-168.
88. Goldman, R., E. Ferber, R. Meller, and U. Zor. 1994. A role for reactive oxygen species in zymosan and β-glucan induced protein tyrosine phosphorylation and phospholipase A2 activation in murine macrophages. Biochim. Biophys. Acta 1222:265-276.
89. Greenfield, R. A. 1992. Host defense system interactions with Candida. J. Med. Vet. Mycol. 30:89-104.
90. Greenfield, R. A., V. L. Abrams, K. L. Crawford, and T. L. Kuhls. 1943. Effect of abrogation of natural killer cell activity on the course of candidiasis induced by intraperitoneal administration and gastrointestinal candidiasis in mice with severe combined immunodeficiency. Infect. Immun. 61:2520-2525.
91. Han, Y., and J. E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.
92. Han, Y., S. Kelm, M. H. Riesselman, P. R. Crocker, and J. E. Cutler. 1994 Mouse sialoadhesin is not responsible for Candida albicans yeast cell binding to splenic marginal zone macrophages. Infect. Immun. 62:2115-2118.
93. Hashimoto, T. 1991. In vitro study of contact-mediated killing of Candida albicans hyphae by activated murine peritoneal macrophages in a serum-free medium. Infect. Immun. 59:3555-3561.
94. Hassett, D. J., and M. S. Cohen. 1989. Bacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells. FASEB J. 3:2574-2582.
95. + T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med. 175:1685-1695.
96. Hoffman, O. A., E. J. Olson, and A. H. Limper. 1993. Fungal β-glucans modulate macrophage release of tumor necrosis factor-α in response to bacterial lipopolysaccharide. Immunol. Lett. 37:19-25.
97. Høgåsen, A. K. M., and T. G. Abrahamsen. 1993. Increased C3 production in human monocytes after stimulation with Candida albicans is suppressed by granulocyte-macrophage colony-stimulating factor. Infect. Immun. 61: 1779-1785.
98. Hostetter, M. K. 1990. Perspective in diabetes handicaps to host defense effects of hyperglycemia on C3 and C. albicans. Diabetes 39:271-275.
99. Huffnagle, G. B., J. L. Yates, and M. F. Lipscomb. 1991. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect. Immun. 59:1423-1433.
100. Hume, D. A., and Y. Denkins. 1992. The deleterious effect of macrophage colony-stimulating factor (CSF-1) on the pathology of experimental candidiasis in mice. Lymphokine Cytokine Res. 11:95-98.
101. Hurley, R., and V. C. Stanley. 1969. Cytopathic effects of pathogenic and nonpathogenic species of Candida on cultured mouse epithelial cells: relation to the growth rate and morphology of the fungi. J. Med. Microbiol. 2:63-74.
102. Janusz, M. J., K. F. Austen, and J. K. Czop. 1988. Phagocytosis of heat-killed blastospores of C. albicans by human monocyte β-glucan receptors. Immunology 65:81-185.
103. Jensen, J., A. Vazquez-Torres, and E. Balish. 1992. Poly(I · C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis. Infect. Immun. 60:4549-4557.
104. Jensen, J., T. Warner, and E. Balish. 1993. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J. Infect. Dis. 167:912-919.
105. Jensen, J., T. Warner, and E. Balish. 1994. The role of phagocytic cells in murine resistance to disseminated candidiasis in granulocytopenic mice. J. Infect. Dis. 170:900-905.
106. Jensen, J., T. Warner, C. Johnson, and E. Balish. 1996. Oral immunization of mice against candidiasis. J. Infect. Dis. 174:133-140.
107. Jiang, G. Z., T. Sugiyama, Y. Kato, N. Koide, and T. Yokochi. 1995. Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation. Infect. Immun. 63:2537-2540.
108. Johnston, R. B., and S. L. Newman. 1977. Chronic granulomatous disease. Pediatr. Clin. N. Am. 24:365-376.
109. Jones-Carson, J., A. Vazquez-Torres, and E. Balish. 1995. Defective killing of Candida albicans hyphae by neutrophils from beige mice. J. Infect. Dis. 171:1664-1667.
110. Jones-Carson, J., A. Vazquez-Torres, and E. Balish. B cell-independent selection of memory T cells after mucosal immunization with Candida albicans. J. Immunol., in press.
111. Jones-Carson, J., A. Vazquez-Torres, H. C. van der Heyde, T. Wagner, R. D. Wagner, and E. Balish. 1995. γδ T cell-induced nitric oxide production enhances resistance to mucosal canididiasis. Nat. Med. 1:552-557.
112. Jouault, T., A. Bernigaud, G. Lepage, P. A. Trinel, and D. Poulain. 1994. The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages. Immunology 83:268-273.
113. Jouault, T., G. Lepage, A. Bernigaud, P. A. Trinel, C. Fradin, J. M. Wieruszeski, G. Strecker, and D. Poulain. 1995. Beta-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production. Infect. Immun. 63:2378-2381.
114. Kagaya, K., and Y. Fukazawa. 1981. Murine defense mechanism against C. albicans infection. II. Opsonization, phagocytosis and intracellular killing of C. albicans. Microbiol. Immunol. 25:807-818.
115. Kaplan, S. S., J. R. Lancaster, Jr., R. E. Basford, and R. L. Simmons. 1996. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect. Immun. 64:69-76.
116. Karbassi, A., F. M. Bedker, J. S. Foster, and R. N. Moore. 1987. Enhanced killing of C albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression of mannose receptors. J. Immunol. 139:417-421.
117. Kataoka, M., and M. Tavassoli. 1985. Development of specific surface receptors recognizing mannose-terminal glycoconjugates in cultured monocytes: a possible early marker for differentiation of monocyte into macrophage. Exp. Hematol. 13:44-50.
118. Kennedy, M. T., P. J. Bates, C. L. Wheatley, and M. S. Rohrbach. 1995. Discrete pathways for arachidonic acid release from tannin versus β-glucan-stimulated rabbit alveolar macrophages. J. Leukocyte Biol. 58:241-248.
119. Kennedy, M. J., A. L. Rogers, L. R. Hanselman, D. Soll, and R. J. Yancey, Jr. 1988. Variation in adhesion and cell surface hydrophobicity in C albicans white and opaque phenotypes. Mycopathologia 102:149-156.
120. Khwaja, A., B. Johnson, I. E. Addison, K. Yong, K. Ruthven, S. Abramson, and D. C. Linen. 1991. In vivo effects of macrophage colony-stimulating factor on human monocyte function. Br. J. Haematol. 77:25-31.
121. Kitz, D. J., P. D. Stahl, and J. R. Little. 1992. The effect of a mannose binding protein on macrophage interactions with C. albicans. Cell. Mol. Biol. 38:407-412.
122. Klein, R. S., C. A. Harris, C. B. Small, B. Moll, M. Lesser, and G. H. Friedland. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311:354-358.
123. Kolotila, M. P., A. L. Rogers, E. S. Beneke, and C. W. Smith. 1987. The effects of soluble Saccharomyces cerevisiae mannan on the phagocytosis of C. albicans by mouse peritoneal macrophages in vitro. J. Med. Vet. Mycol. 25:85-95.
124. Konopski, Z., R. Seljelid, and T. Eskeland. 1994. IFN-γ inhibits internalization of soluble aminated β-1,3-D-glucan by macrophages and thereby down-regulates the glucan induced release of TNF-α and IL-1β. Scand. J. Immunol. 40:57-63.
125. Kullberg, B.-J., J. W. Van't Wout, and R. van Furth. 1990. Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1. Infect. Immun. 58:3319-3324.
126. Kwon-Chung, K. J., D. Lehman, C. Good, and P. T. Magee. 1985. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect. Immun. 49:571-575.
127. Laszlo, D. J., P. M. Henson, L. K. Remigio, L. Weinstein, C. Sable, P. W. Noble, and D. W. Riches. 1993. Development of functional diversity in mouse macrophages. Mutual exclusion of two phenotypic states. Am. J. Pathol. 143:587-597.
128. Leenen, P. J., B. P. Canono, D. A. Drevets, J. S. Voerman, and P. A. Campbell. 1994. TNF-α and IFN-γ stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J. Immunol. 153:5141-5147.
129. Lefkowitz, S. S., M. P. Gelderman, D. L. Lefkowitz, N. Moguilevsky, and A. Bollen. 1996. Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase. J. Infect. Dis. 173:1202-1207.
130. Lehrer, R. I. 1975. The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J. Clin. Invest. 55:338-346.
131. Lehrer, R. L. and M. J. Cline. 1969. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infections. J. Clin. Invest. 48:1478-1488.
132. Lehrer, R. I., L. G. Ferrari, J. Patterson-Delafield, and T. Sorrell. 1980. Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans. Infect. Immun. 28:1001-1008.
133. Leijh, P. C. J., M. T. van den Barselaar, and R. van Furth. 1977. Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect. Immun. 17:313-318.
134. Levitz, S., and R. D. Diamond. 1984. Killing of Aspergillus fumigatus spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system. Infect. Immun. 43:1100-1102.
135. Levitz, S. M., H. L. Mathews, and J. W. Murphy. 1995. Direct antimicrobial activity of T cells. Immunol. Today 16:387-391.
136. Levy, R., S. Latzer, J. Sachs, V. Insler, and M. Alkan. 1990. Host defense during pregnancy: monocyte adherence and killing. Isr. J. Med. Sci. 26:361-366.
137. Lew, D. B., C. C. Leslie, P. M. Henson, and D. W. Riches. 1991. Role of endogenously derived leukotrienes in the regulation of lysosomal enzyme expression in macrophages exposed to β-1,3-glucan. J. Leukocyte Biol. 49:266-276.
138. Li, R. K., and J. E. Cutler. 1993. Chemical definition of an epitope/adhesin molecule on Candida albicans. J. Biol. Chem. 268:18293-18299.
139. Limper, A. H., and J. E. Standing. 1994. Vitronectin interacts with Candida albicans and augment organism attachment to the NR8383 macrophage cell line. Immunol. Lett. 42:139-144.
140. Lipscomb, M. F., G. B. Huffnagle, J. A. Lovchik, C. R. Lyons, A. M. Pollard, and J. L. Yates. 1993. The role of T lymphocytes in pulmonary microbial defense mechanisms. Arch. Pathol. Lab. Med. 17:1225-1232.
141. Louie, A., A. L. Balten, M. A. Franke, R. P. Smith, and M. A. Gordon. 1994. Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor-α: an effect that is attenuated by pentoxifyiline, liposomal vesicles, and dexamethasone. J. Antimicrob. Chemother. 34:975-987.
142. Lyall, E. G., G. F. Lucas, and O. B. Eden. 1992. Autoimmune neutropenia of infancy. J. Clin. Pathol. 45:431-434.
143. MacDonald, F., and F. C. Odds. 1980. Inducible proteinase of C. albicans in diagnostic serology and in the pathogenesis of systemic candidosis. J. Med. Microbiol. 13:423-435.
144. Maiti, P. K., R. Kumar, and L. N. Mohapatra. 1980. Candidacidal activity of mouse macrophages in vitro. Infect. Immun. 29:477-482.
145. Maksymiuk, A. W., S. Thongprasert, R. Hopper, M. Lune, V. Fainstein, and G. P. Bodey. 1984. Systemic candidiasis in cancer patients. Am. J. Med. 77(4D):20-27.
146. Marodi, L., J. R. Forehand, and R. B. Johnston. 1991. Mechanisms of host defense against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J. Immunol. 146:2790-2794.
147. Marodi, L., and R. B. Johnston, Jr. 1992. Biochemical basis for the candidacidal mechanisms of human mononuclear phagocytes, p. 315-320. In R. van Furth (ed.), Mononuclear phagocytes. Kluwer Academic Publishers, Boston, Mass.
148. Marodi, L., and R. B. Johnston, Jr. 1993. Enhancement of macrophage candidacidal activity by interferon-γ. Immunodeficiency 4:181-185.
149. Marodi, L., R. Kaposzka, D. E. Campbell, R. A. Polin, J. Csongor, and R. B. Johnston, Jr. 1994. Candidacidal mechanisms in the human neonate. Impaired IFN-γ activation of macrophages in newborn infants. J. Immunol. 153:5643-5649.
150. Marodi, L., H. M. Korchak, and R. B. Johnston. Jr. 1991. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J. Immunol. 146:2783-2789.
151. Marodi, L., S. Schreiber, D. C. Anderson, R. P. MacDermott, H. M. Korchak, and R. B. Johnston, Jr. 1993. Enhancement of macrophage candidacidal activity by interferon-γ. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J. Clin. Invest. 91:2596-2601.
152. Martin, E., A. Stuben, A. Gorz, U. Weller, and S. Bhakdi. 1994. Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans. Antimicrob. Agents Chemother. 38:13-22.
153. Matsushita, M., and T. Fujita. 1992. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J. Exp. Med. 176:1497-1502.
154. Matthews, R., and J. Burnie. 1992. The role of hsp 90 in fungal infection. Immunol. Today 13:345-348.
155. Matthews, R. C., J. P. Burnie, D. Howat, T. Rowland, and F. Walton. 1991. Auto-antibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology 74:20-24.
156. Meister, H., B. Heymer, H. Schafer, and O. Haferkamp. 1977. Role of C. albicans in granulomatous tissue reactions. II. In vivo degradation of C. albicans in hepatic macrophages of mice. J. Infect. Dis. 135:235-242.
157. Merendino, R. A., A. Arena, D. Delfino, S. Zummo, M. Mesiti, S. Chillemi, and L. Bonina. 1992. Generation of superoxide union and candidacidal activity by lipopolysaccharide-treated macrophages from patients affected by neoplasia. J. Chemother. 4:35-40.
158. Miller, R. A., and B. E. Britigan. 1997. Role of oxidants in microbial pathophysiology. Clin. Microbiol. Rev. 10:1-18.
159. Minami, A., K. Kujimoto, Y. Ozaki, and S. Nakamura. 1988. Augmentation of host resistance to microbial infection by recombinant human interleukin-1-alpha. Infect. Immun. 56:3116-3120.
160. Miyazaki, T., S. Kohno, K. Mitsutake, S. Maesaki, K. Tanaka, N. Ishikawa, and K. Hara. 1995. Plasma (1→3)-β-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J. Clin. Microbiol. 33:3115-3118.
161. Mohamed, A. M. 1975. Ultrastructural aspects of chronic oral candidosis. J. Oral Pathol. 4:1180-194.
162. Mohr, S., J. S. Stamler, and B. Brune. 1994. Mechanism of covalent modification of glyceraldehyde-3-phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite and related nitrosating agents. FEBS Lett. 348:223-227.
163. Morrison, R. P., and J. E. Cutler. 1991. In vitro studies of the interaction of murine phagocytic cells with C. albicans. J. Reticuloendothel. Soc. 29: 23-33.
164. Movy, R., A. Fischer, E. Vilmer, R. Seger, and C. Griscelli. 1989. Incidence, severity and prevention of infections in chronic granulomatous disease. J. Pediatr. 114:555-560.
165. Mukherjee, S., M. Feldmesser, and A. Casadeval. 1996. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J. Infect. Dis. 173:1222-1231.
166. Murphy, J. W. 1990. Immunity to fungi. Curr. Opin. Immunol. 2:360-367.
167. Murray, H. W., and D. M. Cartelli. 1983. Killing of intracellular Leishmania donovani by human mononuclear phagocytes: evidence for oxygen-dependent and -independent leishmanicidal activity. J. Clin. Invest. 72:32-44.
168. Murray, H. W., R. Y. Rubin, S. M. Carriero, A. M. Harris, and E. A. Jaffee. 1985. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs. oxygen-independent activity against intracellular Toxoplasma gondii. J. Immunol. 134:1982-1988.
169. Narayanan, R., W. A. Joyce, and R. A. Greenfield. 1991. Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect. Immun. 59:2116-2119.
170. Naslund, P. K., W. C. Miller, and D. L. Granger. 1995. Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells. Infect. Immun. 63:1298-1304.
171. Nathan, C., and Q. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918.
172. Nathan, C. F., and J. B. Hibbs. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.
173. Nelson, R. D., N. Shibata, R. P. Podzorski, and M. J. Herron. 1991. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action. Clin. Microbiol. Rev. 4:1-19.
174. Nielsen, H., A. Kharazmi, and V. Faber. 1986. Blood monocyte and neutrophil functions in the acquired immune deficiency syndrome. Scand. J. Immunol. 24:291-296.
175. Noble, P. W., P. M. Henson, C. Lucas, M. Mora-Worms, P. C. Carre, and D. W. Riches. 1993. Transforming growth factor-β primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine/paracrine mechanism. J. Immunol. 151:979-989.
176. Nottet, H. S., L. de Graaf, N. M. de Vos, L. J. Bakker, J. A. van Strijp, M. R. Visser, and J. Verhoef. 1993. Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type I infection. J. Infect. Dis. 168:84-91.
177. Nunoshiba, T., T. de Rojas-Walker, J. S. Wishnok, S. R. Tannenbaum, and B. Demple. 1993. Activation by nitric oxide of an oxidative-stress response that defends Escherichia coli against activated macrophages. Proc. Natl. Acad. Sci. USA 90:9993-9997.
178. Odds, F. C. 1979. Candida and candidosis. University Park Press, Baltimore, Md.
179. Odds, F. C. 1985. Morphogenesis in Candida albicans. Crit. Rev. Microbiol. 12:45-93.
180. Odds, F. C. 1994. Pathogenesis of Candida infections. J. Am. Acad. Dermatol. 31:S2-S5.
181. Odds, F. C., C. E. Webster, P. Mayuranathan, and P. D. Simmons. 1988. Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis. J. Med. Vet. Mycol. 26:277-283.
182. Odell, E. W., and A. W. Segal. 1991. Killing of pathogens associated with chronic granulomatous disease by the non-oxidative microbicidal mechanisms of human neutrophils. J. Med. Microbiol. 34:129-135.
183. Ofek, I., R. F. Rest, and N. Sharon. 1992. Non-opsonic phagocytosis of microorganisms. Phagocytes use several molecular mechanisms to recognize, bind and eventually kill microorganisms. ASM News 58:429-435.
184. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1992. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor-α required as a costimulatory factor for interferon gamma-induced activation. Proc. Natl. Acad. Sci. USA 15:8676-8680.
185. Pacelli, R., D. A. Wink, J. A. Cook, M. C. Krishna, W. DeGraff, N. Friedman, M. Tsokos, A. Samuni, and J. B. Mitchell. 1995. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J. Exp. Med. 182:1469-1479.
186. Parry, M. F., R. K. Root, J. A. Metcalf, K. K. Delaney, L. S. Kaplow, and W. J. Richar. 1981. Mycloperoxidase deficiency: prevalence and clinical significance. Ann. Intern. Med. 95:293-301.
187. Patterson-Delafield, J., F. J. Martinez, and R. I. Lehrer. 1980. Microbicidal cationic proteins of rabbit alveolar macrophages: a potential host defense mechanism. Infect. Immun. 30:180-192.
188. Patterson-Delafield, J., D. Szklarek, F. J. Martinez, and R. I. Lehrer. 1981. Microbicidal cationic proteins of rabbit alveolar macrophages: amino acid composition and functional attributes. Infect. Immun. 31:723-731.
189. Pearsall, N. N., B. L. Adams, and R. Bunni. 1978. Immunologic responses to C. albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J. Immunol. 120:1176-1180.
190. Pecyk, R. A., E. B. Fraser-Smith, and T. R. Matthews. 1989. Efficacy of interleukin-1-β against systemic Candida albicans infections in normal and immunosuppressed mice. Infect. Immun. 57:3257-3258.
191. Peterson, E. M., and R. A. Calderone. 1978. Inhibition of specific amino acid uptake in Candida albicans by lysosomal extracts from rabbit alveolar macrophages. Infect. Immun. 21:506-513.
192. Peterson, P. K., E. Gaziano, H. J. Suh, M. Devalon, L. Peterson, and W. F. Keane. 1985. Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages. Infect. Immun. 49:232-218.
193. Poulain, D., V. Hopwood, and A. Vernes. 1985. Antigenic variability of Candida albicans. Crit. Rev. Microbiol. 12:223-270.
194. Poutsiaka, D. D., M. Mengozzi, E. Vannier, B. Sinha, and C. A. Dinarello. 1993. Cross-linking of the β-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production. Blood 82:3695-3700.
195. Pryor, W. A., and G. L. Squadrito. 1995. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 268:L699-L722.
196. Puccetti, P., L. Romani, and F. Bistoni. 1995. A Th1-Th2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol. 3:237-240.
197. Qian, Q., M. A. Jutila, N. Van Rooijen, and J. E. Cutler. 1994. Elimination of mouse macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000-5008.
198. Ray, T. L., A. Hanson, L. F. Ray, and K. D. Wuepper. 1979. Purification of a mannan from C. albicans which activates serum complement. J. Invest. Dermatol. 73:269-274.
199. Ray, T. L., and K. D. Wuepper. 1976. Activation of the alternative (properdin) pathway of complement by C. albicans and related species. J. Invest. Dermatol. 67:700-703.
200. Redmond, H. P., K. Hofmann, J. Shou, P. Leon, C. J. Kelly, and J. M. Daly. 1992. Effects of laparotomy on systemic macrophage function. Surgery 111:647-655.
201. Redmond, H. P., J. Shou, H. J. Gallagher, C. J. Kelly, and J. M. Daly. 1993. Macrophage-dependent candidacidal mechanisms in the murine system. J. Immunol. 150:3427-3433.
202. Rhoads, J. L., D. C. Wright, R. R. Redfield, and D. S. Burke. 1987. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 257:3105-3107.
203. Riipi, L., and E. Carlson. 1990. Tumor necrosis factor (TNF) is induced in mice by Candida albicans: role of TNF in fibrinogen increase. Infect. Immun. 58:2750-2754.
204. Robinson, J. E., B. A. Harvey, and J. F. Soothill. 1978. Phagocytosis and killing of bacteria and yeast by human milk cells after opsonisation in aqueous phase of milk. Br. Med. J. 1:1443-1445.
205. Rogers, T. J., and E. Balish. 1980. Immunity to Candida albicans. Microbiol. Rev. 44:660-682.
206. Rogers, T. J., E. Balish, and D. D. Manning. 1976. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J. Reticuloendothel. Soc. 20:291-298.
207. Romani, L., and D. H. Howard. 1995. Mechanisms of resistance to fungal infections. Curr. Opin. Immunol. 7:517-523.
208. Romani, L., A. Mencacci, E. Cenci, P. Mosci, G. Vitellozzi, U. Grohmann, P. Puccetti, and F. Bistoni. 1992. Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells. J. Infect. Dis. 166: 1384-1392.
209. + subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility of vaccine-induced resistance. J. Immunol. 150:925-931.
210. + subset differentiation in Candida albicans-infected mice. Infect. Immun. 61:3769-3774.
211. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, S. Wolf, P. Puccetti, and F. Bistoni. 1994. Interleukin-12 but not interferon-γ production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol. 24:909-915.
212. Romani, L., S. Mocci, C. Bietta, L. Lanfaloni, P. Puccettti, and F. Bistoni. 1991. Th1 and Th2 cytokine secretion patterns in murine candidiasis: assodation of Th1 responses with acquired resistance. Infect. Immun. 59:4647-4654.
213. Rosati, E., L. Scaringi, P. Cornacchione, K. Fettucciari, R. Sabatini, R. Rossi, and P. Marconi. 1995. Cytokine response to inactivated Candida albicans in mice. Cell. Immunol. 162:256-264.
214. Rosseau, S., W. Seeger, H. Pralle, and J. Lohmeyer. 1994. Phagocytosis of viable Candida albicans by alveolar macrophages: flow cytometric quantification. Am. J. Physiol. 267(2 Pt. 1):L211-L217.
215. Rothemel, C. D., B. Y. Rubin, E. A. Jaffe, and H. W. Murray. 1986. Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages. J. Immunol. 137: 689-692.
216. Rutherford, M. S., A. Witsell, and L. B. Schook. 1993. Mechanisms generating functionally heterogeneous macrophages: chaos revisited. J. Leukocyte Biol. 53:602-618.
217. Sadomy, H. F., and R. A. Fromtling. 1988. Interactions between macrophages and fungi, p. 179-205. In M. R. Escobar and J. P. Utz (ed.), The reticuloendothelial system. Plenum Publishing Corp., New York, N.Y.
218. Sakurai, T., N. Ohno, and T. Yadomae. 1996. Effects of fungal β-glucan and interferon-γ on the secretory functions of murine alveolar macrophages. J. Leukocyte Biol. 60:118-124.
219. Saltarelli, C. G., K. A. Gentile, and S. C. Mancuso. 1975. Lethality of Candida strains as influenced by the host. Can. J. Microbiol. 21:648-654.
220. Saral, R. 1991. Candida and Aspergillus infections in immunocompromised patients: an overview. Rev. Infect. Dis. 13:487-492.
221. Sasada, M., and R. B. Johnston. 1980. Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J. Exp. Med. 152:85-98.
222. Sasada, M., A. Kubo, T. Nishimura, T. Kakita, T. Moriguchi, K. Yamamoto, and H. Uchino. 1987. Candidacidal activity of monocyte-derived human macrophages: relationship between Candida killing and oxygen radical generation by human macrophages. J. Leukocyte Biol. 41:289-294.
223. Sato, T., Y. Endo, M. Matsushita, and T. Fujita. 1994. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose binding protein. Int. Immunol. 6:665-669.
224. Sawyer, R. T., R. E. Garner, and J. A. Hudson. 1992. Effects of lectins on hepatic clearance and killing of Candida albicans by the isolated perfused mouse liver. Infect. Immun. 60:1041-1046.
225. Sawyer, R. T., and A. G. Harmsen. 1989. The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans. Mycopathologia 108:95-105.
226. Sawyer, R. T., M. N. Horst, R. E. Garner, J. Hudson, P. R. Jenkins, and A. L. Richardson. 1990. Altered hepatic clearance and killing of Candida albicans in the isolated perfused mouse liver model. Infect. Immun. 58: 2869-2874.
227. Sawyer, R. T., M. N. Moon, and E. S. Beneke. 1976. Hepatic clearance of Candida albicans in rats. Infect. Immun. 14:1248-1255.
228. Sawyer, R. T., M. N. Moon, and E. S. Beneke. 1981. Trapping and killing of Candida albicans by Corynebacterium parvum-activated livers. Infect. Immun. 32:945-950.
229. Schuit, K. E. 1979. Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils. Infect. Immun. 24:932-938.
230. Scott, P., S. James, and A. Sher. 1985. The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine-activated macrophage cell line. Eur. J. Immunol. 15:553-558.
231. Scully, S. P., G. B. Segei, and M. A. Lichtman. 1984. Calcium exchange and ionized cytoplasmic calcium in resting and activated human monocytes. J. Clin. Invest. 74:589-599.
232. Shepherd, V. L., and J. R. Hoidal. 1990. Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor. Am. J. Respir. Cell Mol. Biol. 2:335-340.
233. Smith, C. B. 1985. Candidiasis: pathogenesis, host resistance and predisposing factors, p. 53-70. In G. P. Brodey and V. Fainstein (ed.), Candidiasis. Raven Press, New York, N.Y.
234. Smith, P. D., C. L. Lamerson, S. M. Banks, S. S. Saini, L. M. Wahl, R. A. Calderone, and S. M. Wahl. 1990. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for C. albicans. J. Infect. Dis. 161:999-1005.
235. Sobel, J. D., G. Muller, and H. R. Buckley. 1984. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect. Immun. 44:576-580.
236. Sohnle, P. G., M. M. Frank, and C. H. Kirkpatrick. 1976. Deposition of complement components in the cutaneous lesions of chronic mucocutaneous candidiasis. Clin. Immunol. Immunopathol. 5:340-350.
237. Spaccapelo, R., L. Romani, L. Tonnetti, E. Cenci, A. Mencacci, G. Del Sero, R. Tognellini, S. G. Reed, P. Puccetti, and K. Bistoni. 1995. TGF-β is important in determining the susceptibility or resistance in mice infected with Candida albicans. J. Immunol. 155:1349-1360.
238. Stahl, P. D. 1992. The mannose receptor and other macrophage lectins. Curr. Opin. Immunol. 4:49-52.
239. Stanley, V. C., and R. Hurley. 1967. Growth of Candida species in cultures of mouse epithelial cells. J. Pathol. Bacteriol. 94:301-315.
240. Stanley, V. C., and R. Hurley. 1969. The growth of Candida species in cultures of mouse peritoneal macrophages. J. Pathol. 97:357-366.
241. Stein, D. K., S. E. Malawista, G. Van Blaricom, D. Wysong, and R. D. Diamond. 1995. Cytoplasts generate oxidants hut require added neutrophil granule constituents for fungicidal activity against Candida albicans hyphae. J. Infect. Dis. 172:511-520.
242. Sullivan, P. A., C. Y. Yin, C. Molloy, M. D. Templeton, and M. G. Shepherd. 1983. An analysis of the metabolism and cell wall composition of C. albicans during germ-tube formation. Can. J. Microbiol. 29:1514-1525.
243. Super, M., and R. A. Ezekowitz. 1992. The role of mannose-binding proteins in host defense. Infect. Agents Dis. 1:194-199.
244. Syverson, R. E., H. Buckley, J. Gibian, and G. M. Ryan. 1979. Cellular and humoral immune status in women with chronic Candida vaginitis. Am. J. Obstet. Gynecol. 134:624-627.
245. Tabona, P., A. Mellor, and J. A. Summerfield. 1995. Mannose binding protein is involved in first-line host defence: evidence from transgenic mice. Immunology 85:153-159.
246. Tachilbana, K., G. Chen, D. S. Huang, P. Scuderi, and R. R. Watson. 1992. Production of tumor necrosis alpha by resident and activated murine macrophages. J. Leukocyte Biol. 51:251-255.
247. Tashjian, J. H., C. B. Coulam, and J. A. Washington II. 1976. Vaginal flora in asymptomatic women. Mayo Clin. Proc. 51:557-561.
248. Thompson, H. L., and J. M. A. Wilton. 1992. Interaction and intracellular killing of Candida albicans blastospores by human polymorphonuclear leukocytes, monocytes and monocyte-derived macrophages in aerobic and anaerobic conditions. Clin. Exp. Immunol. 87:316-321.
249. Tonnetti, L., R. Spaccapelo, E. Cenci, A. Mencacci, P. Puccetti, R. L. Coffman, F. Bistoni, and L. Romani. 1995. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur. J. Immunol. 25:1559-1565.
250. Van der Meer, J. W. M., P. C. J. Leijh, M. van der Barselaar, and R. van Furth. 1978. Functions in phagocytic cells in chronic mucocutaneous candidiasis. Br. Med. J. 1:147-148.
251. Van't Wout, J. W., I. Linde, P. C. J. Leyh, and R. van Furth. 1988. Contribution of granulocytes and monocytes to resistance against experimental disseminated C. albicans infection. Eur. J. Clin. Microbiol. Infect. Dis. 7: 736-741.
252. Van't Wout, J. W., R. Poell, and R. van Furth. 1992. The role of BCG/PPD-activated macrophages in resistance against systemic candidiasis in mice. Scand. J. Immunol. 36:713-719.
253. Van't Wout, J. W., R. Poell, and R. van Furth. 1992. Intracellular killing of C. albicans by activated peritoneal macrophages, p. 534-539. In R. van Furth (ed.), Mononuclear phagocytes. Kluwer Academic Publishers, Boston, Mass.
254. Van't Wout, J. W., J. W. M. Van der Meer, M. Barza, and C. A. Dinarello. 1988. Protection of neutropenic mice from lethal C albicans infection by recombinant interleukin 1. Eur. J. Immunol. 18:1143-1146.
255. Vazquez, N., H. R. Buckley, D. M. Mosser, and T. J. Rogers. 1995. Activation of murine resident peritoneal macrophages by a cell wall extract of Candida albicans. J. Med. Vet. Mycol. 33:385-393.
256. Vazquez-Torres, A., J. Jones-Carson, and E. Balish. 1994. Candidacidal activity of macrophages from immunocompetent and congenitally immunodeficient mice. J. Infect. Dis. 170:180-188.
257. Vazquez-Torres, A., J. Jones-Carson, and E. Balish. 1995. Nitric oxide production does not directly increase macrophage Candidacidal activity. Infect. Immun. 63:1142-1144.
258. Vazquez-Torres, A., J. Jones-Carson, and E. Balish. 1996. Peroxynitrite contributes to the Candidacidal activity of nitric oxide-producing macrophages. Infect. Immun. 64:3127-3133.
259. Vazquez-Torres, A., J. Jones-Carson, T. Warner, and E. Balish. 1995. Nitric oxide enhances resistance of SCID mice to mucosal candidiasis. J. Infect. Dis. 172:192-198.
260. Vecchiarelli, A., F. Bistoni, E. Cenci, S. Perito, and A. Cassone. 1985. In vitro killing of Candida species by murine immunoeffectors and its relationship to the experimental pathogenicity. Sabouraudia J. Med. Vet. Mycol. 23:377-387.
261. Vecchiarelli, A., M. Dottorini, C. Cociani, D. Pietrella, T. Todisco, and F. Bistoni. 1993. Mechanism of intracellular Candidacidal activity mediated by calcium ionophore in human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 9:19-25.
262. Vecchiarelli, A., M. Puliti, A. Torosantucci, A. Cassone, and F. Bistoni. 1991. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cell. Immunol. 134:65-76.
263. Vecchiarelli, A., T. Todisco, M. Puliti, M. Dottorini, and F. Bistoni. 1989. Modulation of anti-Candida activity of human alveolar macrophages by interferon-γ or interleukin-1-α. Am. J. Respir. Cell Mol. Biol. 1:49-55.
264. Wagner, D., A. Vazquez-Torres, J. Jones-Carson, T. Warner, and E. Balish. 1996. B cell "knockout" mice are resistant to mucosal and systemic candidiasis of endogenous origin, but susceptible to experimental systemic candidiasis. J. Infect. Dis. 174:589-597.
265. Wang, M., H. Friedman, and J. Y. Djeu. 1989. Enhancement of human monocyte function against C. albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF and macrophage-CSF. J. Immunol. 143:671-677.
266. Warr, G. A. 1980. A macrophage receptor for (mannose/glucosamine)-glycoproteins of potential importance in phagocytic activity. Biochem. Biophys. Res. Commun. 93:737-745.
267. Watanabe, K., K. Kagaya, T. Yamada, and Y. Fukazawa. 1991. Mechanism for candidacidal activity in macrophages activated by recombinant gamma interferon. Infect. Immun. 59:521-528.
268. Weinberg, E. D. 1992. Iron depletion: a defense against intracellular infection and neoplasia. Life Sci. 50:1289-1297.
269. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1989. Risk factors for hospital acquired candidemia. A matched case-control study. Arch. Intern. Med. 149:2349-2353.
270. Wherry, J. C., R. D. Schreiber, and E. R. Unanue. 1991. Regulation of gamma interferon production by natural killer cells in SCID mice: roles of tumor necrosis factor and bacterial stimuli. Infect. Immun. 59:1709-1715.
271. White, T. C., S. H. Miyasaki, and N. Agabian. 1993. Three distinct secreted aspartyl proteinascs in Candida albicans. J. Bacteriol. 175:6126-6133.
272. Wildfeuer, A., H. Laufen, and O. Haferkamp. 1991. Interactions of fluconazole and phagocytic cells. Mycoses 34(Suppl. 1):53-57.
273. Williams, J. D., J. K. Czop, and K. F. Austen. 1984. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. J. Immunol. 132:3034-3040.
274. Witkin, S. S. 1987. Immunology of recurrent vaginitis. Am. J. Reprod. Immunol. Microbiol. 15:34-37.
275. Witkin, S. S., J. Hirsch, and W. J. Ledger. 1986. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am. J. Obstet. Gynecol. 155:790-795.
276. Yamada, Y., H. Saito, H. Tomioka, and J. Jidoi. 1987. Relationship between the susceptibility of various bacteria to active oxygen species and to intracellular killing by macrophages. J. Gen. Microbiol. 133:2015-2021.
277. Yamaguchi, H., S. Abe, and Y. Tokuda. 1993. Immunomodulatory activity of antifungal drugs. Ann. N. Y. Acad. Sci. 685:447-457.
278. Yamamura, M., and H. Valdimarsson. 1977. Participation of C3 in intracellular killing of C. albicans. Scand. J. Immunol. 6:591-594.